MSD - Profile
✉ Email this page to a colleague
Drugs and US Patents for MSD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msd Sub Merck | ISENTRESS HD | raltegravir potassium | TABLET;ORAL | 022145-002 | May 26, 2017 | RX | Yes | Yes | 7,754,731*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | AP | RX | Yes | No | RE44733*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | AP | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
| Msd | PREVYMIS | letermovir | PELLETS;ORAL | 219104-002 | Aug 30, 2024 | RX | Yes | Yes | RE46791 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Msd | VERQUVO | vericiguat | TABLET;ORAL | 214377-001 | Jan 19, 2021 | RX | Yes | No | 11,439,642 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Msd Sub Merck | STEGLATRO | ertugliflozin | TABLET;ORAL | 209803-002 | Dec 19, 2017 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
